Search Results  for '600664.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Harbin Pharmaceutical Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 Feb 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - HARBIN PHARMACEUTICAL GROUP COMPANY LIMITED (600664-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Feb 2015 Thomson Reuters Stock Report 10 $25.00

Wright Investors Service Comprehensive Report for Harbin Pharmaceutical Group Company Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

23 Feb 2015 Wright Reports 56 $75.00

Will Harbin Pharmaceutical Group Co., Ltd. Deliver Top-Shelf Performance?

19 Feb 2015 Sadif Analytics Prime 12 $25.00

Is Harbin Pharmaceutical Group Co., Ltd. a Good Long-Term Investment?

17 Dec 2014 Sadif Analytics Prime 12 $25.00

Is Harbin Pharmaceutical Group Co., Ltd. a Good Long-Term Investment?

24 Sep 2014 Sadif Analytics Prime 12 $25.00

Can Harbin Pharmaceutical Group Co., Ltd. Rebound?

16 Jul 2014 Sadif Analytics Prime 12 $25.00

Harbin Pharmaceutical Group Holding Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review

Harbin Pharmaceutical Group Holding Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review Summary Harbin Pharmace...

15 May 2014 GlobalData 23 $125.00

Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review

Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review Summary Harbin Pharmaceutical G...

08 Apr 2014 GlobalData 23 $125.00

Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review

Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review Summary Harbin Pharmaceutical G...

10 Jan 2014 GlobalData 23 $125.00